StockWatch
·

ROYAL ORCHID HOTELS LTD.

BSE: 532699

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
53.51
-2.7%+10.4%
Expenditure
49.77
+3.6%+14.0%
Net Profit
2.82
-85.8%-21.9%
OPM %
18.65%
-33.74pp-4.46pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.0016.7533.5050.2567.00Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Reports

Revenue Surged 36%; Profit Collapsed 39%. The Gap Explains Why Guidance Is Gone.

asset-light expansion · ICONIQA ramp-up · profit stall

Result verdictFollow-upQ1 FY2720 Aug 20266 minConsumer & Retail

Revenue growth masked by profit decline; execution risk remains high

asset-light expansion · ICONIQA ramp-up · PAT stall

TranscriptDeep diveQ1 FY2720 Aug 20266 minConsumer & Retail

Royal Orchid Hotels: consol PAT falls 39% YoY to ₹6.8 Cr as finance costs triple

hospitality sector · net margin compression · finance cost surge

ResultsQ1 FY2711 Aug 20263 minConsumer & Retail
Latest
Board Meeting11 Aug, 1:33 pm

Royal Orchid Hotels: consol PAT falls 39% YoY to ₹6.8 Cr as finance costs triple

Royal Orchid Hotels' consolidated PAT fell 39.3% YoY to ₹6.79 Cr (₹6.42 Cr attributable to owners) even as consolidated revenue rose 36.1% YoY to ₹107.21 Cr, against ₹11.19 Cr PAT and ₹78.77 Cr revenue a year ago. Sequentially both lines eased — revenue down 5.3% and PAT down 17.3% from Q4 FY26's ₹113.17 Cr/₹8.22 Cr — a typical post-peak-season pullback for a hotel chain rather than a fresh deterioration. Consolidated EPS was ₹2.34 versus ₹3.99 a year ago. Neither this quarter nor the year-ago quarter carried exceptional items (Q4 FY26 had a ₹2.17 Cr impairment-reversal gain), so the YoY read is on a clean, comparable basis. The profit decline sits entirely below the operating line. EBITDA margin (EBITDA/total income) was effectively flat at 28.7% versus 28.6% a year ago, and EBITDA itself grew 39.1% YoY to ₹32.93 Cr — broadly consistent with management's prior-call expectation of "revenue and EBITDA growth." The squeeze came from finance costs, which more than tripled YoY to ₹13.22 Cr (from ₹3.94 Cr, +235%), and depreciation & amortisation, up 125% to ₹11.53 Cr (from ₹5.13 Cr) — together erasing the EBITDA gain by the time it reaches PBT. That scale of finance-cost increase sits uneasily against management's own framing last quarter of "modest capex... funded by strong internal cash reserves," making it the one clause of prior commentary this print strains against even as top-line and EBITDA growth held up. No verifiable consensus PAT estimate for this quarter turned up in search — this is a small-cap with thin formal coverage — though a pre-print MarketsMojo note had already flagged "weak financials and bearish technicals," consistent with the net-margin compression seen here. Standalone PAT fell a milder 21.9% YoY to ₹2.82 Cr on just 9.8% standalone revenue growth (₹52.22 Cr vs ₹47.56 Cr), well below the 36.1% consolidated pace — the topline expansion is concentrated in subsidiaries and managed/revenue-share properties (new launches in Tirupati and Ahmedabad went live during the quarter) rather than the parent's own hotels. Auditors issued a qualified review report on both statements, citing unresolved SEBI/NCLT proceedings over whether erstwhile subsidiary KSDPL should be treated as a subsidiary rather than an associate, with the NCLT matter next heard on 20 August 2026 and the SEBI matter on 13 August 2026. Separately, the board reiterated the record date (28 August 2026) for the FY26 final dividend of ₹2.5/share approved in May; no new dividend accompanied this result. No standalone management press release was available for this filing, so the statement's own notes are the only management commentary on record this quarter. Going into Q2 FY27, the trajectory to watch is whether finance costs stay near this quarter's ₹13.22 Cr run-rate or ease as new properties season in, whether the Q1 concall finally brings the FY27-28 quantitative targets management deferred last quarter, and the outcome of the KSDPL NCLT/SEBI proceedings given the qualified audit opinion.

11 Aug 2026, 01:33 pm

Corporate Events

Board MeetingROHLTD
2026
26Sep

Board Meeting

The 40th Annual General Meeting of the Company will be held …

BSE Filing
DividendROHLTD
2026
28Aug

₹2.5 / share

BSE Filing
DividendROHLTD
2026
28Aug

₹2.5 / share

BSE Filing
Board MeetingROHLTD
2026
11Aug

Board Meeting

The meeting of the Board of Directors is scheduled to be hel…

BSE Filing
Board MeetingROHLTD
2026
25May

Board Meeting

To consider and approve the Standalone and Consolidated Audi…

BSE Filing
Board MeetingROHLTD
2026
14Feb

Board Meeting

To consider and approve the unaudited Standalone & Consolida…

BSE Filing
DividendROHLTD
2025
29Aug

₹2.5 / share

BSE Filing
Board MeetingROHLTD
2025
13Aug

Board Meeting

Consider and approve Unaudited Financial Results of the Comp…

BSE Filing
Board MeetingROHLTD
2024
14Nov

Board Meeting

Consider and approve the Unaudited Financial Results

BSE Filing
DividendROHLTD
2024
30Aug

₹2.5 / share

BSE Filing
Board MeetingROHLTD
2024
29May

Board Meeting

Consider and approve the Standalone and Consolidated Audited…

BSE Filing
Board MeetingROHLTD
2023
8Nov

Board Meeting

Consider and approve Standalone and Consolidated Unaudited F…

BSE Filing
Board MeetingROHLTD
2023
7Aug

Board Meeting

Consider and approve Unaudited Financial Results of the Comp…

BSE Filing